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“It is not the strongest or the most intelligent that
survive, but who can best manage change.” e Charles
Darwin
Perhaps the most significant and drastic human adaptation
to change occurs during the first few breaths of postnatal
life, as the fetus transitions from intrauterine to extra-
uterine environment with major rerouting of fetal hemo-
dynamics. At term, successful postnatal transition is
accomplished by a decrease in pulmonary vascular resis-
tance following lung expansion, an increase in systemic
vascular resistance as a result of removal of the placenta,
and the subsequent closure of fetal vascular channels.
Vascular rerouting, exposure to higher oxygen tension, and
neuroendocrine surge all contribute to the significant
redistribution of systemic and organ blood flows to meet
the metabolic and functional demands of extrauterine life.
In the preterm infant, normal physiologic transition is
affected by several factors, including but not limited to
immaturity of organ systems, maternal conditions and
medications, timing of cord clamping, and resuscitation
maneuvers. Understanding of this complex process is crit-
ical in the care of preterm newborns, especially in the
neonatal intensive care setting. The purpose of this article
is to review fetal cardiovascular physiology and the hemo-
dynamic changes during transition following preterm birth
and their clinical relevance.2. Fetal to postnatal transition of the
circulation2.1. Fetal-placental unit
The placenta is the principal site of gas and metabolic ex-
change for the fetus. On the fetal side, blood enters and
exits the placenta by way of the umbilical artery and um-
bilical vein, respectively. Within the placenta, chorionic
villi are bathed in mixed arterio-venous maternal blood
with a pO2 around 55 mmHg
1 and gas exchange occurs as
blood moves across the vessels within the fetal villus tree.
Overall, absolute placental-umbilical blood flow in-
creases with gestational age, but it exhibits a moderate
decrease when normalized for fetal weight. It remains in
the range of 110e125 mL/kg/min in the third trimester of
pregnancy to meet the metabolic demands of the growing
fetus.2 This constitutes about 30% of the overall fetal
biventricular cardiac output.
The fetoplacental unit holds a blood volume of approx-
imately 110 mL per fetal weight in kg. The mean blood
volume of the term infant is estimated to be w80 mL/kg
following immediate cord clamping.3 Based on studies that
used either weight-based estimation or dilutional method,
an additional 20e35 mL/kg of blood is transferred from
placenta to the term infant as a result of placental trans-
fusion when clamping of the umbilical cord is delayed for
up to 5 minutes.4 The volume of placental transfusion is
time-dependent; up to 50% of the volume is transferred
within 1 minute,3 and most of the transfusion is completeby 3 minutes. In preterm infants, delay in clamping of the
umbilical cord results in increased blood volume as well.52.2. Fetal circulation
The distinct feature of the fetal circulation is that it is
routed for parallel flow under physiologic conditions. Both
ventricles work together to provide systemic blood flow
resulting in a systemic cardiac output that is nearly double
of the left ventricular output in postnatal life. Indeed, in
human fetuses during the second half of pregnancy, fetal
biventricular output estimated with Doppler ultrasound
remains fairly constant in the range of 470e503 mL/kg/
min,6 similar to a combined cardiac output of approxi-
mately 450 mL/kg/min as measured with the microsphere
method in fetal lambs.7 Existence and patency of the fetal
channels are key for establishing the parallel circulatory
pattern. After receiving relatively less saturated blood from
the caval veins with a superior vena cava (SVC) dominance,
up to 90% of the right ventricular output is shunted through
the ductus arteriosus (DA) to the descending aorta in the
animal model. Thus, the majority of the right ventricular
output bypasses the unaerated lungs and provides blood
flow to the lower body and placenta. In human fetuses,
however, pulmonary blood flow was reported to be signifi-
cantly higher as estimated with Doppler ultrasound.6
Furthermore, an increase in pulmonary blood flow was
observed after 20 weeks’ gestation, approximating 22e25%
of the combined cardiac output during the third trimester.
The left ventricle receives relatively oxygen-rich blood,
directed from the umbilical vein by the ductus venosus (DV)
via the inferior vena cava and foramen ovale (FO). This
configuration allows for preferential streaming of blood
with the highest oxygen saturation reaching the left side of
the heart, thus, prioritizing oxygen delivery to coronary
arteries and cerebral circulation. After 20 weeks’ gesta-
tion, the right ventricle becomes the predominant pump
and is responsible for approximately 60% of the combined
cardiac output.6,8 A somewhat decreased blood flow to the
left atrium secondary to decrease in DV shunt flow and a
more restrictive FO in later gestation have been suggested
as important contributing factors to the right ventricular
predominance.9 Figure 1 depicts the fetal circulation and
the blood flow changes from 20 weeks, 30 weeks, to 40
weeks of gestation, respectively.
The patency of the DA is primarily maintained by nitric
oxide and prostaglandins synthesized within ductal tissue in
the low intrauterine oxygen environment. Premature
closure of the DA, either spontaneous or drug-induced, has
been documented in case reports and case series, and this
can result in right heart congestion, persistent pulmonary
hypertension postnatally, or fetal demise.10 The role of the
DV as a critical fetal channel is less obvious. Relatively
oxygen-rich blood from the placenta returns to the heart by
either passing through the liver, or being shunted directly
to the IVC via the DV. During midgestation, w30% of the
umbilical venous blood is shunted through the DV, and it
decreases to only 20% between 30 weeks and 40 weeks of
gestation. In utero closure of DV in the human fetus has
varying fetal impact, ranging from normal fetal growth to
fetal demise, while experimental obstruction of DV in fetal
Figure 1 Changes in fetal blood flow distribution as a percentage of combined cardiac output and umbilical venous flow are
organized according to increases in gestational age. Note the increase in pulmonary blood flow and decreased shunting through the
foramen ovale as gestational age advances. These changes contribute to establishment of right ventricular dominance.
CCO Z combined cardiac output; DA Z ductus arteriosus; DV Z ductus venosus; FO Z foramen ovale; LVO Z left ventricular
output; RVO Z right ventricular output; UV Z umbilical venous flow.
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delivery.3. Transitional circulation
3.1. Early transition
Immediately after birth, cardiovascular transitional physi-
ological changes are highlighted by an initially significant
and later more gradual decrease in pulmonary vascular
resistance after lung aeration. In addition, following the
standard obstetrical practice of immediate cord clamping,
a sudden increase in systemic vascular resistance (SVR)
occurs. However, when physiologic cord clamping is used,
i.e., clamping of the umbilical cord after effective venti-
lation is established, an improved maintenance of cardiac
preload takes place. This is ensured by the increasing pul-
monary blood flow, which gradually replaces the decreasing
placental blood flow as the umbilical vessels contract. As a
consequence, SVR and afterload increase only gradually
(also see later).11 Avoiding the sudden increase in SVR is of
great importance especially for the very preterm neonate
whose immature myocardium is unable to overcome the
associated increase in afterload. When immediate cord
clamping is used, the sudden increase in the afterload
combined with the decrease in preload results in decreased
systemic blood flow in these patients. Therefore, the au-
thors have postulated that very preterm neonates pre-
senting without apparent systemic hypotension are, by
definition, in the compensated phase of shock during theimmediate transitional period.12 In addition to the loss of
the low-resistance placental circulation, neuroendocrine
changes such as increased production and release of cate-
cholamines, renin, angiotensin, and vasopressin also
contribute to the postnatal increase in SVR. These changes
are primarily initiated by the intermittent decrease in ox-
ygen delivery associated with the uterine contractions
during labor. Once systemic blood pressure exceeds pul-
monary pressure, the increased pulmonary blood flow re-
sults in increased left atrial blood return and pressure, the
FO closes, and redirection of the circulatory pattern ensues
from a parallel into a serial pattern although the DA is still
open. As a result of increasing effective pulmonary gas
exchange and the circulatory changes, arterial oxygen
saturation increases from 60e70% at 1 minute to above 90%
within 10 minutes following delivery.13 To complete the
transition, at least in term neonates, DA constricts within
hours after birth and undergoes functional closure by 48e72
hours of life in the majority of healthy neonates.14 How-
ever, in preterm infants ductal closure is often significantly
delayed. Tables 1 and 2 show the blood flow changes in the
systemic circulation in term and preterm neonates.
3.2. Timing of umbilical cord clamping
One of the first standard obstetric maneuvers following
delivery of the preterm infant is the clamping of the um-
bilical cord. As mentioned above, a significant volume of
the fetal-placental blood remains in the placenta immedi-
ately after birth.4,5 There is a growing body of evidence to
support that delayed clamping of the cord in relation to
Table 2 After birth, the very preterm infant (<29 weeks cohort)79 demonstrates a gradual increase in both ventricular output
throughout the 1st 4 postnatal days, attributed to improvement in ventilation and preload and adaptation to the initial abrupt
increase in afterload due to immediate cord clamping. Concomitantly, superior vena cava flow increases. By 3e4 days of
postnatal life, about 20% of patients present with the ductus arteriosus patent and the majority of them shunt left-to-right.
There is currently no data on blood flow distribution changes minutes after birth in premature infants. LVO Z left ventricu-
lar output; PDA Z patent ductus arteriosus; RVO Z right ventricular output; SVC Z superior vena cava.
Transitional central blood flow changes in preterm newborns*
Flow (mL/kg/min) Birth 4e6 hours 24 hours 3e4 d
SVC d 81  26 93  26 106  30
RVO d 264  90 312  83 360  112
LVO d 243  69 294  77 311  93
PDA
(% >1.5 mm)
(% L<e>R flow)
d (37%)
(38%)
(20%)
(22%)
(22%)
(18%)
* Waal K, Early Human Development 2014, Transitional hemodynamics in preterm infants with respiratory management strategy
directed at avoidance of mechanical ventilation.
Table 1 The healthy term infant demonstrates minimal changes in right ventricular output after birth and the ductus arte-
riosus shunts left-to-right during the 1st day. Left ventricular output is lowered by Day 2 of postnatal life as the patent ductus
arteriosus functionally closes. LVOZ left ventricular output; PDAZ patent ductus arteriosus; RVOZ right ventricular output;
SVC Z superior vena cava.
Transitional central blood flow changes in healthy term newborns
Birth Post-transitional
Flow (mL/kg/min) 3e7 min 9e14 min 15e19 min 4e6 h 24e48 h
SVCz d d d 68 (32e166) 89 (54e167)
RVO*
,y 200  32 204  34 197  47 216 (122e338) 207  47
LVO*
,y 169  42 186  26 180  27 193 (148e278) 156  24
PDA*
,y (flow or pattern) Net (Le>R)
1  46
Net (Le>R)
35  54
Net (Le>R)
57  52
Le>R (76%)
Re>L (14%)
Closing (14%)
100% closed or restrictive
* Noori S, Jpeds 2012, Transitional changes in cardiac and cerebral hemodynamics in term neonates at birth.
y Kluckow M, Neonatology 2012, Non-invasive assessment of early transitional circulation in healthy term infants.
z Skinner JR, Arch Dis Child Fetal Neonatal Ed 2008, Echocardiographic assessment of blood flow volume in the superior vena cava and
descending aorta in the newborn infant.
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ficial to the infant, especially those delivered preterm. As
mentioned earlier, this practice allows better maintenance
of preload and for extra blood volume to be directed to the
preterm neonate.11,15 Depending on the clinical practice,
the volume of placental transfusion is measured to be
around 20e35 mL/kg in term4 and 12e15 mL/kg in preterm
neonates.5 However, when estimated neonatal blood vol-
ume following delayed cord clamping is extrapolated from
the blood volume measured at w30 minutes of postnatal
life, the estimated volume of placental transfusion is
significantly higher in both term and preterm infants.3
Findings of meta-analyses suggest that delayed cord
clamping in preterm infants improves short-term outcomes:
lower incidence of late-onset sepsis, fewer transfusions,
improved systemic blood pressure16 and decreased use of
vasopressor-inotropes17 and, most importantly, significantly
lower incidence of peri/intraventricular hemorrhage (P/
IVH)18 were found. In 2012, the practice of delaying cord
clamping in preterm infants was first advocated by theAmerican College of Obstetricians and Gynecologists and
endorsed by the American Academy of Pediatrics.19
As briefly mentioned earlier, the potentially deleterious
cardiovascular effects of immediate clamping of the um-
bilical cord include: (1) occlusion of the umbilical vein with
an abrupt drop in right ventricular venous return and thus
preload by 40e50%; and (2) occlusion of the umbilical ar-
tery resulting in elimination of blood flow to the low-
resistance placental circulation, which in turn leads to an
immediate increase in left ventricular afterload. Both the
decrease in preload and the increase in afterload nega-
tively affect cardiac contractility and output. In preterm
infants with limited cardiac reserve, this drastic hemody-
namic change following immediate cord clamping has a
negative impact on postnatal circulatory adaptation.
Indeed, premature infants following immediate cord
clamping have lower right ventricular output and lower SVC
flow compared with preterm infants with delayed cord
clamping20 or umbilical milking during the first 48 hours of
postnatal life.16 Furthermore, in preterm infants with
Transitional Hemodynamics in Preterm Neonates 11delayed cord clamping or umbilical cord milking, regional
cerebral oxygen saturation is higher in the first 24e36 hours
of life, compared with immediate cord clamping.21 Finally,
as also mentioned earlier, preterm infants who undergo
delayed cord clamping or umbilical cord milking have
higher initial mean blood pressure16 and require less vaso-
pressor use or volume administration.17 While these find-
ings are encouraging, their exact clinical implications as
well as effects on short- and long-term outcomes remain to
be further investigated in randomized controlled trials.11
Interestingly, in asphyxiated infants, placental trans-
fusion appears to occur in utero, as their blood volume is
higher than that of nonasphyxiated infants born after im-
mediate cord clamping.22 However, more research is
needed to determine the role of physiologic cord clamping
in depressed preterm infants who may appear asphyxiated
and require immediate resuscitation.
4. “Hypotension” in preterm infants in the
transitional period
In the preterm infant, circulatory maladaptation is most
commonly recognized clinically as hypotension when
compensatory mechanisms are overwhelmed or absent.
Although studies have shown early hypotension to be
associated with P/IVH and poor neurodevelopment
outcome in extremely premature infants,23 retrospective
studies found that subsequent efforts to maintain blood
pressure within a certain “normal range” with anti-
hypotensive agents do not appear to have improved clinical
outcomes.24 However, no appropriately designed, pro-
spective study has compared treatment of hypotension
with placebo (no treatment). Interestingly, findings of a
prospective trial suggest that neonates responding to
dopamine or epinephrine administration with increased
blood pressure and cerebral tissue oxygenation do as well
from a neurodevelopmental standpoint as their non-
hypotensive counterparts.25
Most importantly, using blood pressure alone without
information on systemic and organ blood flow to establish
the diagnosis of compensated or uncompensated shock and
initiate treatment will not lead to resolution of this
problem.26Figure 2 Infants who are normotensive may still have underlying
who are hypotensive, the compensatory mechanisms become inad
From “Workbook in practical neonatology” by Wu T-W, Noori S, Se
PA. Reprinted with permission.One of the reasons for this clinical conundrum is that
hypotension remains difficult to define in the preterm in-
fant.27 As alluded to earlier, in the clinical setting, we often
describe an infant’s hemodynamic status by measuring heart
rate and blood pressure only. Because of its availability and
ease of measurement, blood pressure is routinely assessed
and erroneously in itself may be used as a surrogate measure
of cardiovascular function. From population-based studies
reporting normative blood pressure values in preterm and
term infants, mean blood pressure increases as gestational
and postnatal age increase.28,29 Again, it is imperative to
understand the limitations of such an approach, as blood
pressure is the dependent variable in the simplified Ohm’s
law of fundamental fluid dynamics (pressure
gradient Z flow  resistance). When applied to the car-
diovascular system, the equation becomes:
Mean blood pressure  right atrial pressure Z Cardiac
output  SVR
Thus, mean blood pressure is dependent on the two
other, mathematically independent variables, cardiac
output and SVR. Accordingly, blood pressure may remain
within the “normal range”, even though cardiac output may
be decreased but compensated for an increased SVR.
Similarly, blood pressure may be “normal” when vasomotor
tone is low but it is compensated for an increase in cardiac
output26 (Figure 2). In addition, it is important to note that
normal blood pressure does not equate to normal organ
blood flow. Despite a “normal blood pressure”, end organ
perfusion may still be compromised, as the compensated
phase of shock is about to give way to the uncompensated
phase. Two infants of similar gestational age may have
similar “normal” blood pressure values, but the underlying
state of their organ blood flow may be potentially different
from each other, depending on their capacity to compen-
sate by adjusting their cardiac output and/or local end-
organ vascular resistance. Thus, the inability to assess
organ blood flow accurately on a routine basis makes he-
modynamic evaluations challenging in the clinical setting.
Indirect measures of organ perfusion are commonly
incorporated into the bedside clinical assessment to guide
further management of a particular patient. In mostabnormalities in cardiac output or vasomotor tone. For those
equate. CO Z cardiac output; SVR Z vasomotor tone. Note:
ri I, 2014. Copyright 2014, Elsevier/Saunders Co; Philadelphia,
12 T.-W. Wu et alinstances, these include capillary refill time (CRT), lactic
acid level, and urine output. A CRT greater than 3 seconds
is generally considered as abnormal. Of note is that CRT can
be influenced by the site of evaluation, the ambient tem-
perature (higher temperature leads to a shorter CRT), and
medications. As for the site of assessment, the sternum and
forehead are considered most appropriate sites to assess
perfusion. In addition, CRT was reported to have 55%
sensitivity and 81% specificity in detecting low SVC flow in
preterm infants of less than 30 weeks’ gestation during the
immediate transitional period.30 Lactic acidosis develops
when tissue perfusion decreases to the point that increased
oxygen extraction cannot further support tissue energy
demand and anaerobic metabolism commences. This usu-
ally happens as compensatory mechanisms are exhausted
and shock reaches its uncompensated phase. Furthermore,
when organ perfusion is severely affected and perfusion
virtually “shuts down” in a given organ, lactic acid accu-
mulates locally and will not become evident until circula-
tion improves and the “lactic acid wash out” phenomenon
occurs. Thus, in cases where circulation appears to have
improved, increasing lactic acid levels might be the sign of
organ reperfusion and the return of hemodynamic stability.
Contrary to lactic acidosis, the development of oliguria is
an early finding in neonatal shock as it occurs in the
beginning of the compensated phase. In the immediate
transitional period after birth, stress hormone concentra-
tions such as serum arginine vasopressin, epinephrine,
norepinephrine, and serum renin-angiotensin are elevated
and largely explain the diminished urine output seen in
healthy term and relatively well preterm infants during the
first 24 hours of postnatal life. In preterm infants, the
immature renal tubules are unable to absorb solutes and
water despite a decreased glomerular filtration rate,
leading to a higher fractional excretion of solutes and thus
a relatively higher urine output. Consequently, urine output
may not accurately reflect renal perfusion and may falsely
reassure the clinician, as long as the patient is only in the
compensated phase of shock.
Functional echocardiography has been increasingly used
for the bedside assessment of cardiac function such as
myocardial contractility and cardiac output. Importantly,
due to the presence of fetal channels, right and left ven-
tricular output does not simply equate to pulmonary and
systemic blood flow, respectively. Right ventricular output
represents systemic blood return plus interatrial flow
through a patent foramen ovale, while left ventricular
output overestimates systemic blood flow if left-to-right
ductal shunting is present. Indeed, the preterm infant is
capable of increasing the left ventricular output well above
300 mL/kg/min to compensate for the flow through a he-
modynamically significant patent ductus arteriosus in an
attempt to maintain systemic and, importantly, cerebral
blood flow.31 Another caveat is that, even in preterm in-
fants with a closed ductus arteriosus, correlation between
blood pressure and left ventricular output during the first
24 hours following birth is poor (r Z 0.38).32 In the pres-
ence of fetal shunts, SVC blood flow, an assessment of the
blood returning from the upper body and brain, has been
used as a more accurate surrogate measure of systemic
blood flow compared with ventricular output measure-
ments alone.33 Although a significant association betweenlow SVC flow and abnormal developmental outcome at 3
years of age has been reported, no association was found
between treatment of these patients with an inotrope or a
vasopressor-inotrope and long-term outcome.34
Thus, the therapeutic goal to maintain blood pressure
within a reference range oversimplifies neonatal circulatory
dynamics and may be misleading for the clinician. However,
the debate over whether to treat abnormal blood pressure
versus blood flow is nugatory as it is the understanding of
their relationships that would aid the clinician in formu-
lating a physiologically relevant management plan. Design
and execution of randomized control trials to answer such
questions are extremely challenging and unlikely to be
successful because of the need for timely parental consent
and the refusal of most neonatologists to leave “hypoten-
sion” untreated.35
Specific pharmacological management of neonatal hy-
potension is beyond the scope of this article, and the
reader is directed to other reviews on this subject.28,364.1. Preterm myocardium in the transitional period
Under normal conditions immediately after birth, left
ventricular output increases significantly because of an
increased heart rate, increased left ventricular end-
diastolic volume due to increased pulmonary blood flow,
increased inotropy secondary to circulating catechol-
amines, and improved left ventricular wall compliance due
to decreased right ventricular systolic and diastolic load.37
In the healthy term infant, the highly contractile state and
high left ventricular output gradually decreases over the
first 1e2 days after birth as the patent ductus arteriosus
(PDA) constricts and venous return to the left atrium nor-
malizes. The left ventricle assumes the role of the domi-
nant ventricle with subsequent developmental increase in
cardiomyocyte size and number. In the preterm newborn,
although Frank-Starling relationships are preserved and the
baseline contractile state immediately after birth is higher
than in children and adults, the properties of the immature
myocardium render this population more vulnerable to
circulatory compromise during the immediate transitional
period. These include fewer contractile elements, higher
water content, greater surface-to-volume ratio, and a
reliance on L-type calcium channels that utilize extracel-
lular calcium, instead of the sarcoplasmic reticulum
(intracellular calcium stores), as a source of the second
messenger driving cardiomyocyte contraction.
Earlier studies found that, during the first 24 hours after
delivery, more than one-third of preterm infants born at
less than 30 weeks’ gestation have low SVC flow. However,
by 48 hours of postnatal life, SVC flow remained low only in
about 5% of these infants.38 Interestingly, more recent
studies have found a lower proportion of very preterm ne-
onates to present with low SVC flow. It is tempting to
speculate that improvements in obstetric and neonatal
cardiorespiratory care may be responsible for this finding. A
recent study examining arterial blood pressure trends in
extremely preterm infants (23e26 and 6/7-weeks’ gesta-
tion) during the 1st 24 hours of postnatal life found arterial
blood pressure to be the lowest during the 1st 5 hours,
followed by a steady increase thereafter at a rate of
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period when the cord is clamped immediately, the sudden
increase in SVR exceeds the immature myocardium’s ca-
pacity to maintain adequate contractility and output.
However, the myocardium adapts over the course of the 1st
24e48 hours as SVC flow, right ventricle output and arterial
blood pressure normalize. There is emerging evidence that
the extent of this initial period of vulnerability sets the
stage for a hypoperfusion-reperfusion cycle and, in a
portion of preterm infants, injury to the premature
brain.23,40 Details of this intriguing phenomenon are
described in the section on cerebral autoregulation below.4.2. Other factors affecting myocardial function in
the transitional period
1. Perinatal asphyxia
In addition to the developmental immaturity of the
myocardium, other factors contribute to myocardial
dysfunction in the preterm and term neonate. Hypoxic
insult in perinatal asphyxia can have a negative impact on
the heart of the newborn. Cardiac function is depressed
with decreased stroke volume and cardiac output,41 leading
to cardiogenic shock if the insult is severe. The severity of
cardiac dysfunction after perinatal asphyxia correlates with
elevated cardiac enzymes.42 Of note, although acidosis has
been shown to affect myocardial function negatively in
adult humans and animal studies, the preterm myocardium
appears to tolerate acidosis as low as pH 7.02 without ev-
idence of altered myocardial contractility during the first 2
postnatal weeks.43 This observation challenges the con-
ventional approach to aggressively treat acidosis to prevent
myocardial depression in the preterm infant. More studies
are needed to determine if correcting acidosis with an
alkalinizing agent improves myocardial function in this
population.
2. Neonatal sepsis and fetal inflammatory response
syndrome
Neonatal sepsis affects the vasomotor tone of the infant,
which, if severe and uncompensated by the increase in
cardiac output, will lead to systemic hypoperfusion and
shock. Histological chorioamnionitis is a common finding in
preterm deliveries, especially in those with preterm pro-
longed rupture of membrane (PPROM).44 Fetal inflamma-
tory response syndrome (FIRS) is an intrauterine condition
characterized by elevated fetal proinflammatory cytokines
and is associated with unfavorable neonatal outcome.45
Data in literature on the effects of chorioamnionitis or
FIRS on fetal myocardial function are scant. One retro-
spective study using indirect Doppler echocardiographic
markers of function and flow found an alteration in ven-
tricular diastolic function in fetuses with PPROM, marked
by a higher left ventricular compliance compared to fetuses
without PPROM.46 This effect was more pronounced if am-
niotic fluid culture was positive for microorganisms. In
another retrospective study, preterm infants less than 25
weeks’ gestation with histopathological proof of placental
or cord inflammation displayed higher heart rate, requiredmore inotropic and vasopressor support and volume boluses
in the first 24 hours of postnatal life, but had similar
ejection fraction when compared with preterm controls
without fetal inflammation.47 Again, more studies are
needed to elucidate the effects of chorioamnionitis or FIRS
on transitional hemodynamic changes in preterm infants.
3. Fetal growth restriction
Fetal growth restriction is associated with myocardial
remodeling and dysfunction. Cardiac remodeling may be an
adaptive attempt in the face of increasing placental resis-
tance and hypoxia to deliver more oxygenated blood to the
brain and heart. Indeed, fetal echocardiographic studies in
fetal growth restriction show decreased ventricular
compliance, indicating a “stiffer” left ventricle and resul-
tant diastolic dysfunction.48 Postnatally, infants with in-
trauterine growth restriction (IUGR) display a relatively
hypertrophied ventricular septum and left ventricular
dilatation. Serum brain natriuretic peptide concentration
is also elevated in IUGR infants during the first postnatal
days.49 While appropriate-for-gestational age infants in-
crease left ventricular cardiac output and stroke volume,
and decrease left myocardial performance index (a marker
of ventricular dysfunction) and heart rate during the first 5
days of postnatal life, IUGR infants do not exhibit a similar
pattern of postnatal adaptation. Instead, left myocardial
performance index and left ventricular stroke volume
remain unchanged and cardiac output is maintained pri-
marily by a higher overall heart rate when compared with
appropriate-for-gestational age controls.50 Hence, preterm
infants with IUGR are born with decreased myocardial
reserve and display abnormal postnatal hemodynamic
adaptation.
5. Early hemodynamic effects of patent ductus
arteriosus
PDA results from the failure of the DA to close spontane-
ously in the early postnatal period leading to persistent
shunting of blood between the systemic and pulmonary
circulations. The direction and magnitude of shunting
depend on the size of the DA and the difference between
systemic and pulmonary pressures and the impedances in
the two circulations. In extremely low birth weight infants,
PDA closes spontaneously without treatment in up to 50% of
cases.51 The clinical challenges stem from our very limited
ability to predict if PDA will close spontaneously in a given
patient, and from the fact that the hemodynamic conse-
quences of a PDA become clinically evident usually only
days after birth. This gives the false perception that PDA is
not hemodynamically significant during the early transi-
tional period. Data indicate that a large ductal diameter is
associated with decreased SVC flow at 5 hours of postnatal
life; however, this effect is no longer observed at 24e48
hours after delivery.38 To compensate for the decreased
systemic blood flow resulting from the left-to-right shunting
via the PDA, the preterm myocardium adapts with an in-
crease in contractility and left ventricular output (LVO).
However, despite the significant compensatory increase in
LVO, decreased systemic perfusion in the lower body,
14 T.-W. Wu et alindicated by reversed diastolic flow in the descending
aorta, has been demonstrated in preterm neonates with a
large PDA.52 This effect was observed starting at 4 hours
after delivery, with nearly half of the neonates being
affected by 24 hours of age. Similar findings were reported
in preterm neonates with respiratory distress syndrome.53
In these patients, the hemodynamically significant PDA
(hsPDA), defined as a ductal diameter 1.5 mm with color
Doppler and a left atrium-to-aortic-root ratio 1.4, was
associated with increased LVO and decreased blood flow in
abdominal aorta. Doppler measurements of blood flow in
celiac, superior mesenteric, and renal arteries also showed
decreased mean flow velocities and increased resistance
indices. However, anterior cerebral artery flow parameters
used as a surrogate of cerebral blood flow remained similar
to that of the control group without a hsPDA. The differ-
ences in LVO and regional organ blood flow have dis-
appeared following medical closure of PDA. In many cases
of untreated hsPDA, as pulmonary vascular resistance
continues to decrease, there is only a limited ability of the
supra-normal LVO to maintain adequate systemic blood
flow. In turn, signs of pulmonary overcirculation gradually
become more evident and might result in the development
of pulmonary hemorrhagic edema.54
A number of studies have reported association between
PDA and various adverse outcomes in preterm neo-
nates.54e56 However, none of the clinical trials has
demonstrated improvement in long-term outcomes
following treatment of PDA.57 In prophylactic trials, the
investigators have used the most aggressive approach to
treat all preterm neonates based on predefined gestational
age or birth weight. The largest randomized clinical trial,
the Trial of Indomethacin Prophylaxis in Preterm Infants,51
was designed to use intravenous indomethacin as prophy-
laxis to treat the PDA in all infants with birth weight be-
tween 500 g and 999 g in the “treatment” group. This trial
and the subsequent meta-analysis of prophylactic PDA
treatment revealed similar results: there was a reduction in
overall incidence of PDA and grade III and IV P/IVH, but no
significant differences in the rate of bronchopulmonary
dysplasia, overall mortality, and death or severe neuro-
developmental disability at 18e36 months corrected age
were identified.51,58 However, there remain several con-
cerns over the generalizability of the findings of the Trial of
Indomethacin Prophylaxis in Preterm Infants.59
Studies evaluating treatment of presymptomatic and
symptomatic PDA have reported similar findings regarding
long-term outcomes. In the RCT that evaluated efficacy and
safety of ibuprofen compared with a placebo,60 extremely
preterm infants were randomized to one of the treatment
groups prior to 72 hours of postnatal life if they had evidence
of ductal shunting on echocardiogram but no clinical symp-
toms of a PDA. The investigators found that the proportion
of neonates with symptomatic PDA requiring rescue treat-
ment with indomethacin was significantly lower in the
ibuprofen group. However, surgical ligation of PDA was
similar in the ibuprofen and placebo groups. There was no
difference in mortality, retinopathy of prematurity, necro-
tizing enterocolitis, P/IVH, and bronchopulmonary dysplasia
between the two groups. Another RCT compared early (at 3
days of age) versus late (at 7 days of age) treatment of PDA
that was evident on echocardiography using indomethacin,and it found overall improvement in the closure rate in the
early group by postnatal Day 9. However, there was no dif-
ference in surgical ligation rates, mortality, and other
morbidities (necrotizing enterocolitis, sepsis, progression of
P/IVH), and no evidence of respiratory advantage was noted
in the early treatment group.61 While the authors reported
higher incidence of renal complications in the early treat-
ment group, less than half of the neonates randomized to
the late treatment group were actually exposed to indo-
methacin. When predictors of PDA closure were analyzed
separately, delayed treatment, lower gestational age, larger
diameter of PDA, lower left-to-right shunt velocity on
postnatal Day 3, and antenatal exposure to indomethacin
within 48 hours of delivery were identified as independent
predictors of the failure of ductal closure.
Thus, the major clinical challenge concerning the PDA
is the dilemma of whether to treat a PDA in general, and if
so, when and how to intervene. While the data in litera-
ture remain controversial, it is the opinion of these au-
thors that early treatment of the subpopulations of
preterm neonates that are more likely to develop com-
plications of a hsPDA is likely to be justifiable and might
lead to improvement in both short- and long-term out-
comes. Supportive evidence for this approach comes from
the limited observations in the DETECT trial.62 Hemody-
namic determinants of a hsPDA such as a ductal diameter
>1.5 mm, left atrium-to-aortic-root ratio >1.4, the ductal
shunt pattern and reversal of diastolic flow in the
descending aorta, evaluated during the first 6e12 hours of
postnatal life can potentially identify these high-risk pa-
tients. Continuous assessment of organ blood flow using
comprehensive hemodynamic monitoring systems, com-
plemented using point-of-care Doppler ultrasound mea-
surements of systemic, cerebral, renal, and mesenteric
blood flow, holds the promise to further enhance our
diagnostic ability and also to allow monitoring of the
response to intervention in these patients.6. Cerebrovascular autoregulation
Adequate cerebral blood flow (CBF) is critical for brain
oxygenation and nutrient supply, as well as the removal of
pCO2 and metabolic waste. CBF is normally maintained
relatively constant over a range of blood pressures by
varying arterial and arteriolar tone through complex
autoregulatory mechanisms.63 This is known as cerebral
autoregulation illustrated as an autoregulatory plateau
between the two ends of pressure passivity (Figure 3).
Cerebral blood flow autoregulation appears to be intact in
healthy term and well preterm infants, but the range of the
autoregulatory plateau is narrow and the upper and lower
blood pressure values are in debate. Some studies have
shown premature infants receiving intensive care to main-
tain a constant blood flow at and above systemic blood
pressure ranges of 25e30 mmHg.64,65 Again, it is accepted
that the autoregulatory plateau in the extremely prema-
ture infants is much narrower than in term infants and is
attenuated or absent in the sick and distressed
neonate.66,67 It is also likely that the autoregulatory blood
pressure range changes as the patient’s condition changes
and that CBF autoregulation is not an “on or off”
Figure 3 In the preterm infant, the blood pressure range at
which cerebral blood flow remains relatively constant is un-
known and can be present, attenuated, or absent. Please note
though that cerebral blood flow autoregulation is not perfect
and there is and approximately 10 slope in the autoregulatory
range. Pathological conditions in the infant may alter the slope
of the curve outside the autoregulatory plateau. Note. From
“Autoregulation of cerebral blood flow in newborn babies” by
Greisen G, 2005, Early Human Development, 81, p. 423e8.
Copyright 2005, Elsevier/Saunders Co; Philadelphia, PA.
Adapted with permission. Greisen G. Autoregulation of cerebral
blood flow in newborn babies. Early Hum Dev 2005;81:423e8.
Transitional Hemodynamics in Preterm Neonates 15phenomenon. Thus, depending on the patient’s level of
immaturity and the underlying pathology, it might be pre-
sent, attenuated, or absent in the given patient at any
given time. Pressure passivity likely plays a role in the
development of P/IVH and preterm brain injury in the
critically ill preterm neonate with fluctuating blood pres-
sure and CBF.68 In clinical care, neonatologists will often
set blood pressure goals in an attempt to maintain
adequate CBF and prevent ischemia/hyperperfusion. How-
ever, without the knowledge of where the infant lies within
the cerebrovascular autoregulatory curve in real time,
blood pressure goal becomes a moving target. In addition,
attenuated or absent CBF autoregulation is not restored
rapidly. Therefore, unsuitable titration of medications used
in blood pressure management will likely contribute to
significant CBF fluctuations as blood pressure rapidly
changes with inappropriate increases and/or weaning of
the medications used.36,41,42 Low SVC flow in the first 24
hours has also been associated with P/IVH (Grade 2 or
more) and abnormal neurodevelopmental outcome at 3
years of age; yet only limited association was found be-
tween mean blood pressure in the first 24 hours and
abnormal neurodevelopmental outcome.69,70 Although SVC
flow is an attractive hemodynamic parameter, more studies
are needed to determine if maintaining adequate SVC flow
reduces intraventricular hemorrhage.34,71
Other modifiers of CBF include the arterial tension of
carbon dioxide (PaCO2), pH, and oxygen. Carbon dioxide is
the most potent regulator of CBF. Unlike bicarbonate, CO2
readily penetrates the blood brain barrier and equilibrates
between arterial blood and cerebrospinal fluid rapidly.
Rapid diffusion of CO2 alters the pH of the CBF and the
perivascular tissue and acts on the vascular endothelium to
cause cerebral vasodilatation or vasoconstriction in the
setting of acute hypercapnea (acidosis) or hypocapnea
(alkalosis), respectively.72 Fluctuations in PaCO2 frequently
occur in the immediate postnatal period, when ventilatormanagement for respiratory distress syndrome or other
conditions may be challenging. Hypercapnea have also
been found to disrupt and impair cerebral autoregulation in
very low birth weight infants, diminishing innate protective
mechanisms to maintain a relatively steady CBF.73
Furthermore, extreme aberrations in PaCO2 value in the
first three postnatal days in preterm newborns have been
associated with P/IVH and poor neurodevelopmental
outcome.74,75 Interestingly, a recent prospective study
assessed CBF velocity using Doppler ultrasound at the time
of blood gas analysis in preterm infants less than 30 weeks’
gestation during the first 3 postnatal days, and it found
PaCO2 to have very little-to-no association with CBF ve-
locity on postnatal Day 1.76 The expected relationship be-
tween CBF velocity and PaCO2 was only seen on postnatal
Day 3. The cut-off point at which PaCO2 was associated
with a rapid change in cerebral blood flow velocity was
around 51e53 mmHg for the entire dataset.76 The authors
explained their findings by the accumulating evidence that
the forebrain vasculature of the very preterm neonate does
not function as that of a “vital organ” immediately
following delivery.20 Since all of these patients are believed
to be in the compensated phase of shock at birth, they have
maximally constricted cerebral vessels overriding the
vasoactive effects of perivascular pH changes.12
In summary, a number of factors contribute to compro-
mised systemic and cerebral blood flow in the preterm or
the sick term neonate during the transitional period.
Indeed, the preterm myocardium faces an abrupt increase
in afterload following removal of the placenta with imme-
diate clamping of the cord. In addition, soon after delivery
the myocardium is forced to generate significantly higher
cardiac output in the presence of a hsPDA. Other factors,
such as positive pressure ventilation compromising venous
return, autonomic immaturity, relative adrenal insuffi-
ciency, and perinatal asphyxia are also likely to contribute
to the difficulties of hemodynamic transition. It has been
speculated that, with the improvement of low systemic
blood flow over the next 24e72 hours, a hypoxia-
reperfusion scenario takes place and P/IVH or brain injury
may occur.40,77,787. Summary
While cardiovascular changes in premature infants during
the transitional period are dynamic and complex, with the
interplay between cardiac output, systemic blood flow,
blood pressure, and CBF, premature infants are born with
limited capacity to adjust to the hemodynamic challenges
in the immediate postnatal period. A growing body of evi-
dence suggests that compromised systemic blood flow is
associated with the development of a number of short- and
long-term complications such as P/IVH and persistent
neurological deficits. It has also become obvious that only
certain, albeit not well-defined, subgroups of patients are
at significantly higher risk of complications. These sub-
groups of patients would benefit from targeted preventive
and/or therapeutic interventions the most. Thus, early
recognition of impeding cardiovascular compromise along
with appropriate circulatory support during the transitional
period is crucial, although limited evidence-based
16 T.-W. Wu et alinformation is available for the neonatologists. Continuous,
real-time assessment of both systemic and regional organ
perfusion along with continuously assessed changes in brain
function is the next logical next step that will likely enable
the clinician to develop and subsequently adjust an indi-
vidualized management plan that would be pathophysio-
logically justified and most beneficial for a particular
patient.
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